Question 1

What is the catalog number for Onvatilimab?

Accepted Answer

The catalog number for Onvatilimab is M36670.

Question 2

What sizes are available for Onvatilimab?

Accepted Answer

Onvatilimab is available in the following size(s): 1 g, 500 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg.

Question 3

How many pack sizes does Onvatilimab come in?

Accepted Answer

Onvatilimab is available in 7 different pack sizes.

Question 4

Is Onvatilimab in stock?

Accepted Answer

Onvatilimab is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is Onvatilimab used for?

Accepted Answer

Onvatilimab (JNJ-61610588) is a human IgG1 κ-anti-Vista (T-cell-activated V-domain Ig inhibitor) monoclonal antibody with antitumor activity, potentially used for treating advanced head and neck cancers.

Question 6

Do you offer bulk or custom quantities of this product?

Accepted Answer

Yes. Ordering two or more units, or combining this with other products, usually qualifies for a discount depending on quantity. Contact our sales team with your required volume for a custom quote.

Question 7

Do you provide a Certificate of Analysis (CoA) for this product?

Accepted Answer

A Certificate of Analysis is available for most products upon request. Contact our support team with the lot number to obtain the relevant CoA.

Question 8

Is this product suitable for live cell imaging?

Accepted Answer

Suitability for live cell imaging depends on the specific reagent and conjugate used. Check the datasheet for imaging-specific validation, or contact us for guidance.

Onvatilimab

Product Specifications

CAS Number

Stability

Purity

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

Recombinant Prochlorococcus marinus ATP synthase subunit b (atpF)

Recombinant Prochlorococcus marinus ATP synthase subunit b (atpF)

Methyl 2-bromo-5-chloro-3-fluorobenzoate

Methyl 2-bromo-5-chloro-3-fluorobenzoate

Durvalumab Biosimilar - Anti-PD-L1 mAb - Research Grade

Durvalumab Biosimilar - Anti-PD-L1 mAb - Research Grade